Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
NCT ID:
NCT00790868
Eligibility Criteria:
Inclusion Criteria:
* Male or female outpatients \> 18 years of age with a primary psychiatric diagnosis of panic disorder with or without agoraphobia
* CGI-severity score of 4 or higher
* Physical examination and laboratory findings without clinically significant abnormalities
* Off concurrent psychotropic medication for at least 2 weeks prior to initiation of randomized treatment, OR stable on current medication for a minimum of 6 weeks and willing to maintain a stable dose
* Willingness and ability to comply with the requirements of the study protocol
Exclusion Criteria:
* Agoraphobia sufficiently severe as to limit patient's ability to travel to and participate in weekly sessions Posttraumatic stress disorder, substance use disorder, eating disorder, or organic mental disorder within the past 6 months
* Lifetime history of psychotic disorder, bipolar disorder, or developmental disorder
* Significant suicidal ideation or suicidal behaviors within the past 6 months
* Significant personality dysfunction likely to interfere with study participation
* Serious medical illness or instability for which hospitalization may be likely within the next year
* Patients with a current or past history of seizures (other than febrile seizures in childhood)
* Pregnant women, lactating women, and women of childbearing potential who are not using medically accepted forms of contraception
* Concurrent psychotherapy initiated within 3 months of baseline, or ongoing psychotherapy of any duration directed specifically toward treatment of the panic disorder other than general supportive therapy initiated at least 3 months prior to study
* Prior adequate trial of CBT for panic disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00790868
Study Brief:
Protocol Section:
NCT00790868